NUMA1 and urinary bladder carcinoma: Several systematic reviews [50, 51] also evaluated the significance of urinary biomarkers in bladder cancer, like quantitative nuclear matrix protein 22 (NMP22) and qualitative bladder tumor antigen (BTA).